GammaTile Therapy gives patients a head STaRT in the fight against brain tumors. GammaTile consists of four Cesium-131 seeds embedded in a bioresorbable collagen tile that is implanted at the time of tumor resection surgery. GammaTile begins targeting tumor cells immediately while preserving healthy brain tissue, resulting in improved local control outcomes and reducing the burden of treatment for patients.
An Eloquent Solution To Brain Tumors
- No treatment delay: 88% of the therapeutic dose is delivered within 30 days of resection surgery
- Favorable depth-dose profile optimizes local tumor control while protecting healthy brain tissue
- Radiation seeds are embedded in a collagen tile, which:
-
Provides a structural offset of the radiation source from the brain
-
Enforces uniform radiation-source spacing, both within one tile and between multiple tiles
-
Minimizes local hot and cold spots
Read the clinical publications and award-winning abstracts.
GammaTile is intended to deliver radiation therapy in patients with newly diagnosed malignant and recurrent intracranial neoplasms. For full product and safety information, refer to the instructions for use.